Cargando…

Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines

We characterize the breadth, function and phenotype of innate and adaptive cellular responses in a prevention of Mycobacterium tuberculosis infection trial. Responses are measured by whole blood intracellular cytokine staining at baseline and 70 days after vaccination with H4:IC31 (subunit vaccine c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rozot, Virginie, Nemes, Elisa, Geldenhuys, Hennie, Musvosvi, Munyaradzi, Toefy, Asma, Rantangee, Frances, Makhethe, Lebohang, Erasmus, Mzwandile, Bilek, Nicole, Mabwe, Simbarashe, Finak, Greg, Fulp, William, Ginsberg, Ann M., Hokey, David A., Shey, Muki, Gurunathan, Sanjay, DiazGranados, Carlos, Bekker, Linda-Gail, Hatherill, Mark, Scriba, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547090/ https://www.ncbi.nlm.nih.gov/pubmed/33037320 http://dx.doi.org/10.1038/s42003-020-01288-3

Ejemplares similares

Prevention of Infection with Mycobacterium tuberculosis by H4:IC31® Vaccination or BCG Revaccination in Adolescents
por: Nemes, Elisa, et al.
Publicado: (2018)

Diagnostic Accuracy of Early Secretory Antigenic Target-6–Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube
por: Nemes, Elisa, et al.
Publicado: (2019)

Functional, Antigen-Specific Stem Cell Memory (T(SCM)) CD4(+) T Cells Are Induced by Human Mycobacterium tuberculosis Infection
por: Mpande, Cheleka A. M., et al.
Publicado: (2018)

Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection
por: Mpande, Cheleka A.M., et al.
Publicado: (2021)

MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria
por: Suliman, Sara, et al.
Publicado: (2019)

Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacterium tuberculosis Infection
por: Duffy, Darragh, et al.
Publicado: (2020)

Antigen-Specific T-Cell Activation Distinguishes between Recent and Remote Tuberculosis Infection
por: Mpande, Cheleka A. M., et al.
Publicado: (2021)

Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults
por: Baguma, Richard, et al.
Publicado: (2021)

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses
por: Llibre, Alba, et al.
Publicado: (2022)

Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population
por: Baguma, Richard, et al.
Publicado: (2017)

Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria
por: Graustein, Andrew D., et al.
Publicado: (2018)

Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR
por: Mendelsohn, Simon C., et al.
Publicado: (2022)

Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis
por: Mulenga, Humphrey, et al.
Publicado: (2021)

A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates
por: Rodo, Miguel J., et al.
Publicado: (2019)

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection
por: Musvosvi, Munyaradzi, et al.
Publicado: (2023)

Targeted Gene Expression Profiling of Human Myeloid Cells From Blood and Lung Compartments of Patients With Tuberculosis and Other Lung Diseases
por: Kotze, Leigh Ann, et al.
Publicado: (2022)

Mycobacterium tuberculosis-Specific T Cell Functional, Memory, and Activation Profiles in QuantiFERON-Reverters Are Consistent With Controlled Infection
por: Mpande, Cheleka A. M., et al.
Publicado: (2021)

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
por: Scriba, Thomas J, et al.
Publicado: (2021)

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study
por: Mendelsohn, Simon C, et al.
Publicado: (2021)

Evaluation of a transcriptomic signature of tuberculosis risk in combination with an interferon gamma release assay: A diagnostic test accuracy study
por: Mulenga, Humphrey, et al.
Publicado: (2022)

Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol
por: Bunyasi, Erick Wekesa, et al.
Publicado: (2017)

Multidimensional analysis of immune responses identified biomarkers of recent Mycobacterium tuberculosis infection
por: Lloyd, Tessa, et al.
Publicado: (2021)

Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients
por: Mbandi, Stanley Kimbung, et al.
Publicado: (2022)

The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk
por: Mulenga, Humphrey, et al.
Publicado: (2022)

The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses
por: Tameris, Michele, et al.
Publicado: (2014)

Evaluation of Xpert(®) MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial
por: Bunyasi, Erick Wekesa, et al.
Publicado: (2015)

The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children
por: Mulenga, Humphrey, et al.
Publicado: (2015)

Postnatal Expansion, Maturation, and Functionality of MR1T Cells in Humans
por: Swarbrick, Gwendolyn M., et al.
Publicado: (2020)

Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks
por: Villain, Etienne, et al.
Publicado: (2023)

Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy
por: Darboe, Fatoumatta, et al.
Publicado: (2019)

Antibody tests for diagnosing COVID-19: how relevant are they?
por: Shey, Muki Shehu, et al.
Publicado: (2020)

The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010–2014
por: Brennan, Michael J., et al.
Publicado: (2017)

A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe
por: Geldenhuys, Hennie D., et al.
Publicado: (2015)

Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children
por: Luabeya, Kany Kany A., et al.
Publicado: (2015)

Plasma Type I IFN Protein Concentrations in Human Tuberculosis
por: Llibre, Alba, et al.
Publicado: (2019)

DataPackageR: Reproducible data preprocessing, standardization and sharing using R/Bioconductor for collaborative data analysis
por: Finak, Greg, et al.
Publicado: (2018)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG
por: Tameris, Michele, et al.
Publicado: (2013)

Noninvasive Detection of Tuberculosis by Oral Swab Analysis
por: Luabeya, Angelique K., et al.
Publicado: (2019)

Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals
por: Schmidt, B.‐M., et al.
Publicado: (2017)

Safety and immunogenicity of candidate vaccine M72/AS01(E) in adolescents in a TB endemic setting
por: Penn-Nicholson, Adam, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pvcgkdju5f168o6s2j5su7tr9r